{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:52Z","timestamp":1786991632426,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jcf.2014.09.015","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T21:04:11Z","timestamp":1414011851000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection \u2014 A pilot study"],"prefix":"10.1016","volume":"14","author":[{"given":"Marianne","family":"Skov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tacjana","family":"Pressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Lykkesfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Enghusen","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter \u00d8strup","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Krogh","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tavs","family":"Qvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe","family":"Kr\u00e6mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"H\u00f8iby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Ciofu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2014.09.015_bb0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/thx.52.6.557","article-title":"Pulmonary oxidative stress response in young children with cystic fibrosis","volume":"52","author":"Hull","year":"1997","journal-title":"Thorax"},{"issue":"4 Pt 1","key":"10.1016\/j.jcf.2014.09.015_bb0010","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/ajrccm.156.4.96-11058","article-title":"Lower airway inflammation in infants and young children with cystic fibrosis","volume":"156","author":"Armstrong","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2014.09.015_bb0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1067\/mpd.2002.129847","article-title":"Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis","volume":"141","author":"Sagel","year":"2002","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jcf.2014.09.015_bb0020","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbadis.2011.12.012","article-title":"Oxidative stress and antioxidant therapy in cystic fibrosis","volume":"1822","author":"Galli","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.jcf.2014.09.015_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcn\/77.1.150","article-title":"Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function","volume":"77","author":"Wood","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"395","key":"10.1016\/j.jcf.2014.09.015_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1651-2227.1994.tb13229.x","article-title":"Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant\u2013antioxidant imbalance","volume":"83","author":"Winklhofer-Roob","year":"1994","journal-title":"Acta Paediatr Suppl"},{"issue":"5","key":"10.1016\/j.jcf.2014.09.015_bb0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajcn\/63.5.722","article-title":"Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations","volume":"63","author":"Winklhofer-Roob","year":"1996","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.jcf.2014.09.015_bb0040","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/ajcn\/65.6.1858","article-title":"Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation","volume":"65","author":"Winklhofer-Roob","year":"1997","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.jcf.2014.09.015_bb0045","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ajcn\/67.5.817","article-title":"Nutritional status in cystic fibrosis: where to go from here?","volume":"67","author":"Winklhofer-Roob","year":"1998","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.jcf.2014.09.015_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1203\/00006450-199410000-00013","article-title":"Evidence for increased oxidative damage in patients with cystic fibrosis","volume":"36","author":"Brown","year":"1994","journal-title":"Pediatr Res"},{"issue":"12","key":"10.1016\/j.jcf.2014.09.015_bb0055","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0891-5849(01)00530-5","article-title":"Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation","volume":"30","author":"Hudson","year":"2001","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.jcf.2014.09.015_bb0060","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1152\/jappl.1993.75.6.2419","article-title":"Systemic deficiency of glutathione in cystic fibrosis","volume":"75","author":"Roum","year":"1993","journal-title":"J Appl Physiol"},{"issue":"12","key":"10.1016\/j.jcf.2014.09.015_bb0065","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jcf.2014.09.015_bb0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jcf.2014.09.015_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-acetylcysteine \u2014 a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jcf.2014.09.015_bb0080","first-page":"CD007168","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","volume":"7","author":"Tam","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jcf.2014.09.015_bb0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1183\/09031936.93.02030234","article-title":"N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility","volume":"2","author":"Stafanger","year":"1989","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jcf.2014.09.015_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.201303-0427OC","article-title":"Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial","volume":"188","author":"Griese","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2014.09.015_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0891-5849(94)90019-1","article-title":"The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective","volume":"17","author":"Winkler","year":"1994","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.jcf.2014.09.015_bb0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1742-7843.2011.00822.x","article-title":"Poor antioxidant status exacerbates oxidative stress and inflammatory response to Pseudomonas aeruginosa lung infection in guinea pigs","volume":"110","author":"Jensen","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.jcf.2014.09.015_bb0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2014.09.015_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ppul.1950150204","article-title":"Pulmonary function between 6 and 18years of age","volume":"15","author":"Wang","year":"1993","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2014.09.015_bb0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2014.09.015_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nutres.2011.11.005","article-title":"Ascorbate and dehydroascorbic acid as biomarkers of oxidative stress: validity of clinical data depends on vacutainer system used","volume":"32","author":"Lykkesfeldt","year":"2012","journal-title":"Nutr Res"},{"issue":"11","key":"10.1016\/j.jcf.2014.09.015_bb0125","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1158\/1055-9965.EPI-07-0639","article-title":"Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and long-term stability of plasma samples subjected to acidic deproteinization","volume":"16","author":"Lykkesfeldt","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.jcf.2014.09.015_bb0130","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/clinchem\/47.9.1725","article-title":"Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet\u2013visible spectrophotometry","volume":"47","author":"Lykkesfeldt","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcf.2014.09.015_bb0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0076-6879(94)33053-0","article-title":"Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence","volume":"233","author":"Sattler","year":"1994","journal-title":"Methods Enzymol"},{"issue":"5","key":"10.1016\/j.jcf.2014.09.015_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.06.002","article-title":"Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2\u2032-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry","volume":"47","author":"Henriksen","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/j.jcf.2014.09.015_bb0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF00368326","article-title":"Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes","volume":"75","author":"Rothe","year":"1988","journal-title":"Naturwissenschaften"},{"issue":"12","key":"10.1016\/j.jcf.2014.09.015_bb0150","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.jcf.2014.09.015_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02535748","article-title":"Biokinetics of dietary RRR-alpha-tocopherol in the male guinea pig at three dietary levels of vitamin C and two levels of vitamin E. Evidence that vitamin C does not \u201cspare\u201d vitamin E in vivo","volume":"25","author":"Burton","year":"1990","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.jcf.2014.09.015_bb0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ajcn\/84.2.375","article-title":"Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population","volume":"84","author":"Ford","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.jcf.2014.09.015_bb0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1172\/JCI108760","article-title":"The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis","volume":"60","author":"Farrell","year":"1977","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jcf.2014.09.015_bb0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/CCLM.1999.082","article-title":"Lipid peroxidation and antioxidant defenses in cystic fibrosis patients","volume":"37","author":"Benabdeslam","year":"1999","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.jcf.2014.09.015_bb0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcf.2010.09.005","article-title":"Effect of an antioxidant-rich multivitamin supplement in cystic fibrosis","volume":"10","author":"Sagel","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2014.09.015_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ppul.20041","article-title":"Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation","volume":"38","author":"Lagrange-Puget","year":"2004","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.jcf.2014.09.015_bb0185","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/thx.49.8.738","article-title":"Role of free radicals in the pathogenesis of cystic fibrosis","volume":"49","author":"Brown","year":"1994","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.jcf.2014.09.015_bb0190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0891-5849(94)00172-G","article-title":"Oxidative damage to DNA in patients with cystic fibrosis","volume":"18","author":"Brown","year":"1995","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.jcf.2014.09.015_bb0195","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0891-5849(95)00063-4","article-title":"Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation","volume":"19","author":"Winklhofer-Roob","year":"1995","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"10.1016\/j.jcf.2014.09.015_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/biof.5520080125","article-title":"Enhanced oxidative damage in cystic fibrosis patients","volume":"8","author":"Dominguez","year":"1998","journal-title":"Biofactors"},{"issue":"4","key":"10.1016\/j.jcf.2014.09.015_bb0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ajcn\/61.4.843","article-title":"Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis","volume":"61","author":"Portal","year":"1995","journal-title":"Am J Clin Nutr"},{"issue":"2 Suppl.","key":"10.1016\/j.jcf.2014.09.015_bb0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/07315724.2001.10719028","article-title":"Oxidative stress in cystic fibrosis: dietary and metabolic factors","volume":"20","author":"Wood","year":"2001","journal-title":"J Am Coll Nutr"},{"issue":"6","key":"10.1016\/j.jcf.2014.09.015_bb0215","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11745-999-0397-1","article-title":"Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis","volume":"34","author":"Collins","year":"1999","journal-title":"Lipids"},{"issue":"1\u20132","key":"10.1016\/j.jcf.2014.09.015_bb0220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2007.01.028","article-title":"Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking","volume":"380","author":"Lykkesfeldt","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.jcf.2014.09.015_bb0225","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2014.09.015_bb0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1164\/rccm.200901-0069OC","article-title":"Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening","volume":"180","author":"Sly","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2014.09.015_bb0235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MCP.0b013e328331c8cd","article-title":"The first 2years of life: implications of recent findings","volume":"15","author":"Stick","year":"2009","journal-title":"Curr Opin Pulm Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199314002276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199314002276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T10:11:13Z","timestamp":1689588673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199314002276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1569199314002276"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2014.09.015","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection \u2014 A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2014.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}